Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$6.99 - $9.26 $99,334 - $131,593
-14,211 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.49 - $19.54 $5,985 - $13,775
705 Added 5.22%
14,211 $121,000
Q2 2020

Aug 14, 2020

SELL
$7.44 - $11.29 $55,331 - $83,963
-7,437 Reduced 35.51%
13,506 $141,000
Q1 2020

May 15, 2020

BUY
$6.94 - $14.22 $2,061 - $4,223
297 Added 1.44%
20,943 $196,000
Q4 2019

Feb 13, 2020

BUY
$7.99 - $37.6 $164,961 - $776,289
20,646 New
20,646 $165,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $454M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Amia Capital LLP Portfolio

Follow Amia Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amia Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Amia Capital LLP with notifications on news.